Peipei Chen1, Jian Lu1, and Tao Zhang1
1Department of Radiology,The Third Hospital Affiliated of Nantong University, Nantong, China
Synopsis
Gadoxetate disodium(Gd-EOB-DTPA)is a novel hepatobiliary contrast agent with characteristics of
conventional contrast agents and can also be taken up by liver cells specifically,
which is beneficial in characterization of focal liver lesions. In clinical
practice, some small hemangiomas usually show low signal in transitional phase
of Gd-EOB-DTPA enhanced MRI, defined as Pseudo washout sign(PWS), which can be
easily misdiagnosed as hepatocellular carcinoma (HCC) if diagnostic physician do
not have sufficient experience. Our study intended to improve the understanding
of hepatic hemangiomas with atypical imaging features by summarizing the
imaging features of hepatic hemangioma with PWS in Gd-EOB-DTPA-enhanced MRI.
Introduction
Gadoxetate disodium (Gd-EOB-DTPA) is a
dual-function novel MR contrast agent with both characteristics of traditional
contrast agent and hepatobiliary contrast agent, which improves diagnostic
accuracy and sensitivity of hepatocellular carcinoma ( HCC) [1]. Some small hemangiomas usually show low signal in
transitional phase of Gd-EOB-DTPA enhanced MRI, defined as Pseudo washout sign
(PWS), which is difficult to diagnose when HCC and hepatic hemangiomas coexisting. Our study would compare imaging features of hepatic hemangiomas with and without PWS in Gd-EOB-DTPA enhance MRI, and to summarize
imaging features of hepatic hemangiomas with PWS.Methods
From Jan 2012 to May 2017, we evaluated the imaging information of 62 patients with 83 hemangiomas, investing the enhancement patterns (nodular
enhancement, diffuse homogenous enhancement and arterioportal shunt during the
arterial phase, fill-in enhancement during the portal venous phase, PWS during the
transition phase)(fig.1~6) and visually
assessing the intensity of contrast enhancement (in relation to that of the
liver parenchyma using a four-point scale during each phase : grade 4, clearly
higher; grade 3, moderately higher; grade 2, equal; grade 1, lower) of the
lesions. Chi-square test and Mann-Whitney U test were performed to compare the hemangiomas
with and without PWS .Result
Among 83 hepatic hemangiomas, 16.9%(14) were characterized
with PWS, which were significantly smaller than those without PWS(P<0.05); more
frequently diffuse enhancement, less nodular and fill-in enhancement(P<0.05) in hemangiomas
with PWS than those without; visually determined grades in hemangiomas with PWS
were significantly lower than those without during portal venous phase(P<0.05).Conclusion and discussion
The typical enhancement patterns of hemangiomas are nodular enhancement in
arterial phase, fill-in enhancement in portal
vein phase, delayed enhancement in transition phase. However, Tateyama[2] reported that 48% hepatic
hemangiomas showed PWS enhancement after
Gd-EOB-DTPA enhanced MRI examination. Our study showed that hepatic hemangiomas
with the characterization of being small, showing diffuse enhancement during
arterial phase or lower visually determined grades
during portal venous phase tend to show PWS during the transition phase on Gd-EOB-DTPA enhanced MRI. If necessary, diagnostic physician should
combine these characterizations with T2WI sequence, CT and conventional contrast
medium enhanced MR to avoid misdiagnosis.Acknowledgements
No acknowledgement found.References
[1] Baek
CK,Choi JY,Kim KA,et al.Hepatocellular carcinoma in patients with chronic liver
disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic
MDCT[J].Clinical radiology, 2012, 67(2):148-156.
[2] Tateyama
A,Fukukura Y,Takumi K,et al.Hepatic Hemangiomas: Factors Associated with Pseudo
Washout Sign on Gd-EOB-DTPA-enhanced MR Imaging[J]. Magnetic resonance in
medical sciences : MRMS : an official journal of Japan Society of Magnetic
Resonance in Medicine,2016, 15(1): 73-82.